Delivery Order SPE2DB22D1202-SPE2DB24FUPA5

Award Date 1/30/24
Potential Completion Date 1/31/24
Potential Value $135K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $6,131.46 delivery order is issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $19,404.28 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 4, 2022, with a completion date of August 5, 2022. This order is a part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that covers a comprehensive range of pharmaceutical products and...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of Xarelto 20 mg tablets. The $11,560.22 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 6, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $25,702.98 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 16, 2022 with a completion date of June 17, 2022. The contract is a delivery order issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a broad range of pharmaceutical products and...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $1,409.52 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 29, 2023. The contract has a completion date of June 30, 2023 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract, awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $4,121.91 and an ultimate completion date of May 19, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award is for the delivery of Xarelto 20mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $7,566.24, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm-fixed-price delivery order contract with an ultimate completion date of January 13, 2023. The contract does not have a set-aside designation, reflecting Amerisourcebergen's extensive capabilities in the pharmaceutical distribution market....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., to provide a range of pharmaceutical products and medical supplies. The $1,341.00 firm-fixed-price delivery order covers the delivery of Xarelto 20 mg tablets, with a completion date of January 10, 2022. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Xarelto 20mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $7,036.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm-fixed-price delivery order with a completion date of January 19, 2024. The award was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA) from Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,461.30 firm fixed-price delivery order has a completion date of May 3, 2023. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUPA5
    Delivery Order

This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order is valued at $134,713.86 and has a completion date of January 31, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying essential medications and medical commodities to federal agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.

Generated 5/13/25, 10:31 AM